De l’érythropoïétine recombinante aux agents stimulant l’érythropoïèse

2005, Époétines en ville : quelques répères pour peu de différences, Prescrire, 25, 658 Lin, 1985, Cloning and expression of the human erythropoietin gene, Proc Natl Acad Sci (USA), 82, 7580, 10.1073/pnas.82.22.7580 Jelkmann, 1986, Renal erythropoietin : properties and production, Rev Physiol Biochem Pharmacol, 104, 139, 10.1007/BFb0031014 Flaharty, 1989, Epoetin : human recombinant erythropoietin, Clin Pharm, 8, 769 Constant, 1994, Recormon®, Eprex® : érythropoïétine humaine recombinante, Lyon Pharmaceutique, 45, 495 Martin, 2007, The first human cell line-derived erythropoietin, epoetin-δ (Dynepo®), in the management of anemia in patients with chronic kidney disease, Clin Nephrol, 68, 26, 10.5414/CNP68026 Egrie, 2001, Development and characterization of novel erythropoiesis stimulating protein (NESP), Nephrol Dial Transplant, 16, 3, 10.1093/ndt/16.suppl_3.3 Macdougall, 2007, Pharmacology of darbepoetin alfa, Nephrol Dial Transplant, 22, iv2, 10.1093/ndt/gfm160 Storz, 2008, PEGylated drugs : a concise overview, PharmaChem, 7, 9 Jarsch, 2008, Comparative erythropoietin receptor binding kinetics of CERA and epoetin-beta determined by surface plasmon resonance and competition binding assay, Pharmacology, 81, 63, 10.1159/000109166 Doreau, 2008, Quel positionnement pour les biosomilaires en France ?, Actualités pharmaceutiques hospitalières, 15, 37, 10.1016/S1769-7344(08)70093-3 Schellekens, 2008, The first biosimilar epoetin: but how similar is it ?, Clin J Am Soc Nephrol, 3, 174, 10.2215/CJN.04251007 Prugnaud, 2008, Similarité des médicaments issus des biotechnologies : cadre réglementaire et spécificité, Ann Pharm Fr, 66, 206, 10.1016/j.pharma.2008.07.008 Roger, 2006, Biosimilars: how similar or dissimilar are they ?, Nephrology, 11, 341, 10.1111/j.1440-1797.2006.00594.x Valderrábano, 2003, Pre-dialysis survey on anaemia management, Nephrol Dial Transplant, 18, 89, 10.1093/ndt/18.1.89 Singh, 2008, The optimal hemoglobin in dialysis patients – A critical review, Sem Dialysis, 21, 1, 10.1111/j.1525-139X.2007.00329.x Gebbia, 1991, Recombinant human erythropoietin accelerates recovery from cisplatin induced anemia in cancer patients: Preliminary results, Cancer J, 4, 343 Pelegri, 2007, Impact of erythropoietin treatment on the quality of life of oncologic patients, Clin Transl Oncol, 9, 645, 10.1007/s12094-007-0117-1 Aapro, 2006, Erythropoietin: effects on life expectancy in patients with cancer-related anaemia, Curr Med Res Opin, 22, S5, 10.1185/030079906X159579 Pape, 2007, Alternatives to allogeneic blood transfusions, Best Pract Res Clin Anaesthesiol, 21, 221, 10.1016/j.bpa.2007.02.004 Rosencher, 2003, Érythropoïétine en péri-opératoire, Transfus Clin Biol, 10, 159, 10.1016/S1246-7820(03)00057-0 Rosencher, 1999, Stratégie préopératoire d’épargne sanguine homologue et érythropoïétine en périchirurgie, Transfus Clin Biol, 6, 370, 10.1016/S1246-7820(00)88982-X Saizou, 2004, Érythropoïétine et anémie du prématuré, Arch Ped, 11, 1516, 10.1016/j.arcped.2004.03.013 Eidemak, 1992, Intravenous versus subcutaneous administration of recombinant human erythropoietin in patients on haemodialysis and CAPD, Nephrol Dial Transplant, 7, 526 Yoshioka, 2007, Pharmacokinetic study of darbepoetin alfa: absorption, distribution, and excretion after a single intravenous and subcutaneous administration to rats, Xenobiotica, 37, 74, 10.1080/00498250600987929 MacDougall, 2006, Pharmacokinetics and pharmacodynamics of intravenous and subcutaneous continuous erythropoietin receptor activator (CERA) in patients with chronic kidney disease, Clin J Am Soc Nephrol, 1, 1211, 10.2215/CJN.00730306 Simon, 1995, Érythropoïétine et hypertension artérielle chez l’insuffisant rénal chronique, Rev Med Intern, 16, 457, 10.1016/0248-8663(96)80739-9 Brunet, 1994, Plasma endothelin in haemodialysis patients treated with recombinant human erythropoietin, Nephrol Dial Transplant, 9, 650, 10.1093/ndt/9.6.650 Bohlius, 2006, Cancer-related anemia and recombinant human erythropoietin – An updated overview, Nat Clin Pract Oncol, 3, 152, 10.1038/ncponc0451 Boven, 2005, Epoetin-associated pure red cell aplasia in patients with chronic kidney disease : solving the mystery, Nephrol Dial Transplant, 20, iii33, 10.1093/ndt/gfh1072